Verrica Pharmaceuticals Inc
NASDAQ:VRCA
| Market Cap (Intraday) | 43.14M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $5.13 |
| 50-Day MA | $6.43 |
| 200-Day MA | $6.44 |
Verrica Pharmaceuticals Inc Stock, NASDAQ:VRCA
44 West Gay Street, Suite 400, West Chester, Pennsylvania 19380
United States of America
Phone: +1.434.453.3300
Number of Employees: 71
Description
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.